VIEMED HEALTHCARE, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M |
| Cost of revenue | $114.8M | $91.1M | $70.2M | $54.2M | $43.7M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M |
| Selling, general & administrative | $121.4M | $106.2M | $87.9M | $68.2M | $54.9M |
| Research and development | $3.0M | $3.1M | $2.8M | $2.7M | $2.1M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M |
| Pretax income | $21.8M | $16.2M | $14.4M | $9.0M | $12.5M |
| Income tax expense | $6.4M | $4.8M | $4.1M | $2.8M | $3.4M |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M |
| Balance Sheet | |||||
| Cash and equivalents | $13.5M | $17.5M | $12.8M | $16.9M | $28.4M |
| Current assets | $48.5M | $52.9M | $38.4M | $39.7M | $47.3M |
| Total assets | $199.2M | $177.1M | $154.9M | $117.0M | $118.0M |
| Current liabilities | $41.1M | $37.3M | $32.1M | $18.9M | $17.8M |
| Total liabilities | $55.6M | $43.8M | $41.0M | $19.9M | $23.1M |
| Stockholders' equity | $141.5M | $131.4M | $113.9M | $97.1M | $94.8M |
| Cash Flow Statement | |||||
| Cash from operations | $51.9M | $39.1M | $45.2M | $27.7M | $22.5M |
| Depreciation and amortization | $28.6M | $25.4M | $21.9M | $15.6M | $11.3M |
| Stock-based compensation | $9.1M | $6.3M | $5.8M | $5.2M | $5.2M |
| Capital expenditure | $40.0M | $37.8M | $26.1M | $22.9M | $19.7M |
| Free cash flow | $11.9M | $1.3M | $19.1M | $4.8M | $2.8M |
| Share repurchases | $13.2M | $0 | $0 | $9.6M | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 38.3M · Free float 64.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.